- Identification and Validation of High-Risk Genes Contributing to Poor Prognosis in Multiple Myeloma Patients with chr1q Gain/AmplificationZhang, Shanshan; Cai, Linjing; Huan, Chen; Wang, Yuqi; Liu, Qifa; Wei, Xiaolei65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- CD43 Expression Is an Adverse Prognostic Factor in Newly Diagnosed Multiple MyelomaNing, Xueqin; Wei, Yongqiang; Wei, Xiaolei; Feng, Ru; Chen, Bingyuan; Yi, Zhengshan; Zheng, Zhongxin63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.被引 1
- FABP4 Suppresses the Progress of Multiple Myeloma through Enhancing Alarming Function of Bone Marrow Resident Memory T LymphocytesZhu, Ziang; Li, Yang; Huang, Han-Ying; Chen Shuzhao; Liu, Yang; Liang, Yang; Shu, Lingling65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
会议论文
CRIP1 Upregulated Along with chr1q-Gain Indicates Immune Dysregulation and Portends Poor Outcomes in Multiple Myeloma
3阅读
